Calico Labs emerged as a trailblazing initiative backed by Google to revolutionize our understanding of aging and longevity. Born from the company’s ambitious “moonshot” projects, Calico seeks to unravel the mysteries behind aging, aiming to combat life-shortening diseases with cutting-edge research. Through collaboration with esteemed entities like University of California start-up QB3 and Jackson Labs, the team aspires to unveil genetic factors linked to health and longevity. With an impressive $1.5 billion investment, Calico harnesses advanced technologies to delve deep into the biology of aging, potentially paving the way for transformative health solutions.
In 2013, Google took a bold step into the world of longevity research by launching Calico Labs, a venture dedicated to unraveling the mysteries of aging and related diseases. This initiative is part of Google’s “moonshot” vision, aiming to tackle some of humanity’s most challenging health issues by pushing the boundaries of what science and technology can achieve.
Calico Labs, short for California Life Company, operates with a unique approach by integrating cutting-edge technology and advanced scientific research. The team collaborates closely with leading scientists and institutions, such as the University of California start-up QB3 and Jackson Labs, to explore the intricate relationship between genetics, health, and longevity. These partnerships harness the expertise needed to potentially accelerate breakthroughs in understanding the genetic factors contributing to healthy aging.
With a significant funding boost from Google’s founders, including Larry Page, Calico Labs focuses relentless efforts on uncovering new knowledge that could lead to increased quality and length of life. Despite the complexity of their mission, the team’s ambition is to make aging gracefully a reality for future generations, transforming how we think about growing old. By tapping into the innovative spirit and resources of one of the world’s tech giants, Calico Labs aims to redefine what’s possible in the realm of life extension.
Understanding the Calico journey
Founded in 2013, Calico, or the California Life Company, is the brainchild of Google Ventures and visionary leaders determined to unlock the secrets of living longer, healthier lives. With an impressive funding pool of $1.5 billion, this initiative sets its sights on addressing aging and its associated diseases. Bringing together experts from various scientific fields, Calico blends technology and science to gain insights into the biology of aging. Their collaboration with prominent research entities, such as the University of California start-up QB3, enables them to explore groundbreaking ideas. Calico’s pioneering atmosphere offers researchers the freedom to explore bold hypotheses, aiming to uncover genetic, dietary, and health influences on longevity. For more insights, visit Calico.
A team of seasoned scientists and biotechnologists drives Calico’s mission. They harness advanced technologies that push boundaries beyond state-of-the-art. With a dedication that fosters innovation, Calico’s technology labs work hand-in-hand with researchers to advance hypotheses, aiming to answer critical questions about aging. Such work often involves studying the genetic intricacies of organisms, focused on identifying genes that can signal healthy aging. Their efforts extend beyond theoretical research, as the organization is committed to transforming discoveries into potent new treatments, demonstrated by their collaborative studies on diseases like the Vanishing White Matter Disease. Discover more about their research in Calico’s technology.
The ambitious goals of Calico
Calico sets out on a mission many would deem impossible—understanding the mechanics of aging and finding ways to keep people healthy as they age. Supported by Google’s initiative, labeled as part of its “moonshot” projects, Calico is poised to make significant breakthroughs in tackling aging Google’s bold vision. Calico leverages its resources to delve into why certain species, like the mole-rat, exhibit extraordinary lifespans while others do not. Such studies could lay the foundation for humans to enjoy longer, healthier lifespans. Led by a relentless focus on health and longevity, every effort is made to ensure the discoveries hold the potential to increase human lifespan.
Innovative strategies and collaborations
At the heart of Calico’s strategy is collaboration. Understanding that no single entity holds all the answers, Calico Labs partners with institutions like Jackson Labs, employing a unique blend of resources and expertise to study health and longevity. By funding and developing joint research projects, the company is rechecking and rebuilding life extension ideas from the ground up. Their aim is to pinpoint specific genes associated with healthy aging, allowing them to advance age-related disease studies. By participating in projects such as the FDA START Pilot for life-extension studies, Calico aligns itself with a broader scientific community that seeks to redefine the limits of human potential. Find more about their collaborative efforts Here.
